Skip to main content

Advertisement

Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis

Fig. 4

Synthesis and release of S100A11 by peripheral blood mononuclear cells (PBMCs) and synovial fibroblasts (SFs). PBMCs and SFs from patients with rheumatoid arthritis (RA) synthesize (a, b) and spontaneously release (c, d) higher levels of S100A11 compared to the cells from patients with osteoarthritis (OA). Representative images of protein levels of S100A11 in PBMCs and SFs isolated from patients with RA (n = 4) and patients with OA (n = 4) by western blot

Back to article page